Zoë Alice Bell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zoë Alice Bell has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Asifa Islam
School of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK
1 shared publication - Hannah M. Brown
School of Health and Life Sciences, Teesside University, TS1 3BX Middlesbrough, UK
1 shared publication - Hong Gao
School of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK
1 shared publication - Lautaro Baro
Cytoskeletal Dynamics in Cell Migration and Cancer Invasion Laboratory, Centro de Investigación Príncipe Felipe, 46012 Valencia, Spain
1 shared publication - Louise Davison
School of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK
1 shared publication - Maria Angeles Juanes
Cytoskeletal Dynamics in Cell Migration and Cancer Invasion Lab, Department of Cancer, Centro de Investigación Príncipe Felipe (CIPF)
1 shared publication
Latest Publications
- Open Access
- 21 January 2026
- Published by MDPI AG in Applied Microbiology
- Vol. 6 (1) , 19
Practical Insights and Emerging Trends for Strategic Cloning of Large Biosynthetic Gene Clusters from Bacteria
Cloning large biosynthetic gene clusters (BGCs) is fundamental to unlocking microbial natural product potential for drug discovery and biotechnology. These clusters encode diverse bioactive compounds, but their size, high GC content, and complex architecture pose significant technical challenges. This review scrutinises recent advances in BGC cloning strategies, categorising them into three major groups: (1) direct release-and-capture methods, (2) genome-integrated preconditioning systems, and (3) CRISPR-assisted hybrid platforms. This review compares the strengths, limitations, and reported efficiencies of BGC cloning strategies, highlighting trade-offs in precision, scalability, and workflow complexity. Emerging trends, such as AI-driven genome mining, modular synthetic biology toolkits, and high-throughput automation, are reshaping the cloning landscape, enabling predictive design and streamlined assembly of clusters exceeding 100 kb. By integrating comparative analysis with future perspectives, this review provides outlines on how next-generation strategies will accelerate heterologous expression, natural product discovery, and sustainable biomanufacturing.
- 21 January 2026
- Published by MDPI AG in Applied Microbiology
- Vol. 6 (1) , 19
Open AccessPractical Insights and Emerging Trends for Strategic Cloning of Large Biosynthetic Gene Clusters from Bacteria
Cloning large biosynthetic gene clusters (BGCs) is fundamental to unlocking microbial natural product potential for drug discovery and biotechnology. These clusters encode diverse bioactive compounds, but their size, high GC content, and complex architecture pose significant technical challenges. This review scrutinises recent advances in BGC cloning strategies, categorising them into three major groups: (1) direct release-and-capture methods, (2) genome-integrated preconditioning systems, and (3) CRISPR-assisted hybrid platforms. This review compares the strengths, limitations, and reported efficiencies of BGC cloning strategies, highlighting trade-offs in precision, scalability, and workflow complexity. Emerging trends, such as AI-driven genome mining, modular synthetic biology toolkits, and high-throughput automation, are reshaping the cloning landscape, enabling predictive design and streamlined assembly of clusters exceeding 100 kb. By integrating comparative analysis with future perspectives, this review provides outlines on how next-generation strategies will accelerate heterologous expression, natural product discovery, and sustainable biomanufacturing.